Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gynecologic 1

Conditions

Ovarian Neoplasms 508 Uterine Cervical Neoplasms 361 Endometrial Neoplasms 305 Breast Neoplasms 130 Colorectal Neoplasms 112 Neoplasms 98 Fallopian Tube Neoplasms 90 Carcinoma, Non-Small-Cell Lung 87 Stomach Neoplasms 83 Pancreatic Neoplasms 79 Lung Neoplasms 72 Melanoma 68 Prostatic Neoplasms 67 Carcinoma, Ovarian Epithelial 65 Neoplasm Metastasis 63 Triple Negative Breast Neoplasms 51 Vulvar Neoplasms 50 Squamous Cell Carcinoma of Head and Neck 49 Head and Neck Neoplasms 45 Esophageal Neoplasms 43 Uterine Neoplasms 40 Peritoneal Neoplasms 40 Urinary Bladder Neoplasms 38 Carcinoma, Hepatocellular 35 Carcinoma, Renal Cell 34 Uterine Cervical Dysplasia 31 Sarcoma 31 Papillomavirus Infections 31 Colonic Neoplasms 31 Recurrence 29

Interventions

niraparib 1 dostarlimab 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ovarian Carcinosarcoma × Gynecologic × Clear all

NCT03651206 2026-06-01

ROCSAN

ARCAGY/ GINECO GROUP

Phase 2/3 Recruiting

GynecologicSarcoma

Ovarian Carcinosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡